Chembio Diagnostics, Inc. (CEMI): Price and Financial Metrics


Chembio Diagnostics, Inc. (CEMI)

Today's Latest Price: $4.89 USD

0.04 (-0.81%)

Updated Oct 26 8:41am

Add CEMI to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 58 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

CEMI Stock Summary

  • With a year-over-year growth in debt of 241.5%, Chembio Diagnostics Inc's debt growth rate surpasses 93.38% of about US stocks.
  • The volatility of Chembio Diagnostics Inc's share price is greater than that of 93.08% US stocks with at least 200 days of trading history.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for CEMI comes in at -48.55% -- higher than that of only 8.95% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Chembio Diagnostics Inc are MDRX, HTGM, FLIR, COHU, and RWLK.
  • CEMI's SEC filings can be seen here. And to visit Chembio Diagnostics Inc's official web site, go to chembio.com.

CEMI Stock Price Chart Interactive Chart >

Price chart for CEMI

CEMI Price/Volume Stats

Current price $4.89 52-week high $15.89
Prev. close $4.93 52-week low $2.25
Day low $4.89 Volume 1,590
Day high $4.89 Avg. volume 2,646,316
50-day MA $4.62 Dividend yield N/A
200-day MA $6.03 Market Cap 98.59M

Chembio Diagnostics, Inc. (CEMI) Company Bio


Chembio Diagnostics, Inc., together with its wholly-owned subsidiary, Chembio Diagnostic Systems, Inc., develops, manufactures, markets, and licenses rapid point-of-care (POC) diagnostic tests that detect infectious diseases. The company was founded in 1985 and is based in Medford, New York.


CEMI Latest News Stream


Event/Time News Detail
Loading, please wait...

CEMI Latest Social Stream


Loading social stream, please wait...

View Full CEMI Social Stream

Latest CEMI News From Around the Web

Below are the latest news stories about Chembio Diagnostics Inc that investors may wish to consider to help them evaluate CEMI as an investment opportunity.

Return On Capital Employed Overview: Chembio Diagnostics

During Q2, Chembio Diagnostics's (NASDAQ: CEMI) reported sales totaled $5.11 million. Despite a 66.92% in earnings, the company posted a loss of $7.27 …

Benzinga | October 2, 2020

Chembio submits EUA application for rapid antibody test system

Chembio Diagnostics (CEMI) +5.5% PM, initiated notification process and submission of an application for Emergency Use Authorization ((EUA)) to the U.S. FDA for its new rapid antibody test system, DPP SARS-CoV-2 IgM/IgG.The test system detects antibodies to the Spike Receptor Binding Domain in the blood that the body produces in response to a...

Seeking Alpha | September 9, 2020

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Chembio Diagnostics, Inc. (CEMI)

LOS ANGELES--(BUSINESS WIRE)---- $CEMI #classaction--The Law Offices of Frank R. Cruz reminds investors of the upcoming August 17, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Chembio Diagnostics, Inc. ("Chembio" or the "Company") (NASDAQ: CEMI) common stock between April 1, 2020 and June 16, 2020, inclusive (the “Class Period”). If you are a shareholder who suffered a loss, click here to participate. In April 2020, the Company’s COVID-19 antibody test w

Business Wire | August 14, 2020

CLASS ACTION UPDATE for ENDP, CEMI and BKD: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / July 31, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies.

Yahoo | July 31, 2020

LAWSUITS FILED AGAINST ENDP, CEMI and JCOM - JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS

NEW YORK, NY / ACCESSWIRE / July 31, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below.

Yahoo | July 31, 2020

Read More 'CEMI' Stories Here

CEMI Price Returns

1-mo 4.60%
3-mo -3.55%
6-mo -59.55%
1-year -9.28%
3-year -19.17%
5-year 0.00%
YTD 7.24%
2019 -19.43%
2018 -30.98%
2017 20.59%
2016 27.58%
2015 36.32%

Continue Researching CEMI

Want to see what other sources are saying about Chembio Diagnostics Inc's financials and stock price? Try the links below:

Chembio Diagnostics Inc (CEMI) Stock Price | Nasdaq
Chembio Diagnostics Inc (CEMI) Stock Quote, History and News - Yahoo Finance
Chembio Diagnostics Inc (CEMI) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.9343 seconds.